Other potential side effects may include constipation, diarrhea, or decreased appetite
Safety and tolerability Both agents can cause gastrointestinal adverse effects (e.g
Consistent with the mean of 10% weight loss observed in the naltrexone-bupropion group, which was maintained through 12 months, we observed modest improvements in the obesity-related parameters in several domains relevant to cardiometabolic risks: glycaemic control (HbA1c), lipid metabolism (LDL-C levels), liver parameters (ALT and AST levels, CAP and LS on VCTE)
These pathways control appetite and digestion
Brunilda Nazario, chief medical officer of medical affairs at WebMD told Flow Space
While Mounjaro shows promising results for managing type 2 diabetes and aiding weight loss, you might wonder about the possibility of combining it with other GLP-1 medications